vimarsana.com
Home
Live Updates
Issi Rozen - Breaking News
Pages:
2
3
4
5
6
7
8
Latest Breaking News On - Issi rozen - Page 1 : vimarsana.com
InnovationRx: Base Editing Pioneer Nicole Gaudelli Joins GV
Plus: eGenesis, the startup behind the first pig-human kidney transplant, is targeting hearts and livers next.
New york
United states
Nicole gaudelli
Los angeles
Rick bates
Kate middleton
Landos biopharma
Issi rozen
Mike curtis
Mark cuban
Novo nordisk
Drug administration
Broad institute
Brightside health
Mental health
Supreme court
GV promotes 4 new general partners
Alphabet’s independent VC firm wants to plant a stake in the ground amid a tumultuous market.
United states
Anne sraders
Issi rozen
Luisa beltran
Crystal huang
Brendan bulik sullivan
Jessica verrilli
Cian foley
Jackson fordyce
Mitsubishi corporation
Goldman sachs
Clearlake capital group
Fidelity national information services
Marunouchi climate tech growth fund
Glasswalls syndicate
Mitsubishi heavy industries america
Chroma Medicine Secures $135M in Series B Financing to Advance Breakthrough Epigenetic Editing Technology and Expand Pipeline of Durable Precision Genomic Medicines
/PRNewswire/ Chroma Medicine, Inc., (Chroma) a genomic medicine company pioneering single-dose epigenetic editing therapeutics, today announced the.
New zealand general
New zealand
United kingdom
Al iskandariyah
Catherine stehman breen
Issi rozen
Vic myer
Chroma medicine inc
Atlas venture
Osage university partners
Venture partners
Mubadala capital
Sixth street
Google ventures
Alexandria venture investments
Casdin capital
Aera Therapeutics Launches with $193M in Series A and Series B Financing
FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!
United states
Vicki sato
John maraganore
Issi rozen
David schenkein
Feng zhang
Robert nelsen
Josh wolfe
Vertex pharmaceuticals
Broad institute
Mcgovern institute
Howard hughes medical institute
Aera therapeutics
Akin akinc
Patricia poitras professor
With Aera, CRISPR pioneer Feng Zhang goes after gene therapy s delivery problem
BioPharma
United states
Bob nelsen
Vicki sato
John maraganore
Issi rozen
David schenkein
Feng zhang
Vertex pharmaceuticals
Broad institute
Alnylam pharmaceuticals
Agios pharmaceuticals
Arch venture partners
Akin akinc
Editas medicine
Prime medicine
Lux capital
vimarsana © 2020. All Rights Reserved.